Development of a Semi-Mechanistic Population Pharmacokinetic Model for Predicting Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide Exposure in Plasma and Cellular Matrices During Pregnancy and Postpartum

By afschroeder • November 13, 2025

Yu Y, Brooks KM, Doncel GF, Best BM, Marzinke MA, Mirochnick M, Anderson P, Myer L, Celum C, Heffron R, Coleman J, Davey DJ, Hendrix CW, Momper JD, Bies R, Scott RK. Development of a Semi-Mechanistic Population Pharmacokinetic Model for Predicting Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide Exposure in Plasma and Cellular Matrices During Pregnancy and Postpartum. Clin Pharmacokinet. 2025 Nov 12. doi: 10.1007/s40262-025-01589-y. Epub ahead of print. PMID: 41222898.

Tags: Infectious Diseases, Publications

Using generative AI for healthcare-associated infection surveillance

Morgan DJ, Goodman KE, Branch-Elliman W, Shenoy ES, Salinas JL, Jones M, Singh SP, Schrank GM, Pineles L, AlShanqeeti S, Harris AD, Klein E. Using[...]

Diggs MR, Chu SM, Fitch KV, Olefsky M, Watanabe MG, Erlandson KM, Lu AB, Bloomfield GS, Currier JS, Curran A, Eckard AR, Smith GHR, Sponseller[...]

Minimalistic transcriptomic signatures permit accurate early prediction of COVID-19 mortality

Narendra R, Lydon EC, Phan HV, Spottiswoode N, Neyton LP, Diray-Arce J; IMPACC Network; COMET Consortium; EARLI Consortium; Becker PM, Kim-Schulze S, Hoch A, Pickering[...]